Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7405 p707
17 June 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Government reviews control of entry reforms

A review into the effectiveness of NHS pharmacy “control of entry” reforms introduced in April last year has been launched by the Government.

Health Secretary Patricia Hewitt said that senior Department of Health officials will consider the “effect on access to and the choice of pharmaceutical services for patients, taking account of the new contractual framework”.

The review will also consider progress in implementing the “balanced” package of reforms; their impact for consumers and the retail pharmacy market; and the extent to which the operation of the new regulatory system is proportionate to the aims and objectives of the reforms.

Within that remit they will consider any effect on pharmacy services in rural and socially deprived areas; an analysis of dispensing by community pharmacies, including openings and closures, distances between pharmacies and opening hours; and the quality of community pharmacies following the reforms.

Ms Hewitt has ordered that the review report should be completed and published by the end of October this year.

She said that two remaining measures are in the Health Bill currently going through Parliament: charging for pharmacy applications and ensuring that primary care trusts, when assessing applications, take into account the improvements they would bring to the provision of, or access to, over-the-counter medicines and other health care products and advice.

After the announcement of the review, Pharmaceutical Services Negotiating Committee chief executive Sue Sharpe said: “We were expecting the DoH announcement on the control of entry review. We know from reports from local pharmaceutical committees that there have been large numbers of applications in the first year. The majority of cases using the exemptions to control of entry have been seeking to use the 100-hour pharmacy exemption. Some of these are in locations where demand out of hours is likely to be minimal, and this is therefore the exemption category the PSNC believes is of most concern.

“It is important that contractors who are, or may be affected by new pharmacies using any of the exemptions consider and respond to the consultation. The PSNC has been gathering information about use of the exemptions and will be developing its response in the coming weeks.”

Pharmacists who want to contribute to the review can do so until 12 September 2006.

Back to Top


©The Pharmaceutical Journal